{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "25010554",
  "DateCompleted": {
    "Year": "2015",
    "Month": "02",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "07",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.3390/nu6072572"
    ],
    "Journal": {
      "ISSN": "2072-6643",
      "JournalIssue": {
        "Volume": "6",
        "Issue": "7",
        "PubDate": {
          "Year": "2014",
          "Month": "Jul",
          "Day": "09"
        }
      },
      "Title": "Nutrients",
      "ISOAbbreviation": "Nutrients"
    },
    "ArticleTitle": "Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C status: a randomized controlled trial.",
    "Pagination": {
      "StartPage": "2572",
      "EndPage": "2583",
      "MedlinePgn": "2572-83"
    },
    "Abstract": {
      "AbstractText": [
        "The early indications of vitamin C deficiency are unremarkable (fatigue, malaise, depression) and may manifest as a reduced desire to be physically active; moreover, hypovitaminosis C may be associated with increased cold duration and severity. This study examined the impact of vitamin C on physical activity and respiratory tract infections during the peak of the cold season. Healthy non-smoking adult men (18-35 years; BMI < 34 kg/m2; plasma vitamin C < 45 \u00b5mol/L) received either 1000 mg of vitamin C daily (n = 15) or placebo (n = 13) in a randomized, double-blind, eight-week trial. All participants completed the Wisconsin Upper Respiratory Symptom Survey-21 daily and the Godin Leisure-Time Exercise Questionnaire weekly. In the final two weeks of the trial, the physical activity score rose modestly for the vitamin C group vs. placebo after adjusting for baseline values: +39.6% (95% CI [-4.5,83.7]; p = 0.10). The number of participants reporting cold episodes was 7 and 11 for the vitamin C and placebo groups respectively during the eight-week trial (RR = 0.55; 95% CI [0.33,0.94]; p = 0.04) and cold duration was reduced 59% in the vitamin C versus placebo groups (-3.2 days; 95% CI [-7.0,0.6]; p = 0.06). These data suggest measurable health advantages associated with vitamin C supplementation in a population with adequate-to-low vitamin C status."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Nutrition and Health Promotion, Arizona State University, 500 N. 3rd St., Phoenix, AZ 85004, USA. carol.johnston@asu.edu."
          }
        ],
        "LastName": "Johnston",
        "ForeName": "Carol S",
        "Initials": "CS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Isagenix\u00ae International LLC, 2225 S. Price Rd., Chandler, AZ 85286, USA. gillean.barkyoumb@isagenixcorp.com."
          }
        ],
        "LastName": "Barkyoumb",
        "ForeName": "Gillean M",
        "Initials": "GM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Cancer Treatment Centers of America\u00ae, 14200 W. Celebrate Life Way, Goodyear, AZ 85338, USA. sara.schumacher@ctca-hope.com."
          }
        ],
        "LastName": "Schumacher",
        "ForeName": "Sara S",
        "Initials": "SS"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Nutrients",
    "NlmUniqueID": "101521595",
    "ISSNLinking": "2072-6643"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "PQ6CK8PD0R",
      "NameOfSubstance": "Ascorbic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "blood"
      ],
      "DescriptorName": "Ascorbic Acid"
    },
    {
      "QualifierName": [
        "blood",
        "drug therapy"
      ],
      "DescriptorName": "Ascorbic Acid Deficiency"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Mass Index"
    },
    {
      "QualifierName": [
        "blood",
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dietary Supplements"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Surveys"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Healthy Volunteers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Motor Activity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nutritional Status"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Surveys and Questionnaires"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Wisconsin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}